Furthermore, it is well known that mutation of the transcription factor (TF) RUNX1/AML1 is observed frequently in patients with myelodysplastic syndrome and leukemia, and the mutation is linked to the expression of rRNA and ribosomal proteins (42). This evidence concerns the gene RUNX1 and myelodysplastic syndrome.